NEUBASE THERAPEUTICS INC

CUSIP: 64132K102 Class: COM

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 311,000 Value ($000) $58 Avg Close — Range —
Q4 2022
Shares 311,000 Value ($000) $59 Avg Close — Range —
Q3 2022
Shares 311,000 Value ($000) $123 Avg Close — Range —
Q2 2022
Shares 311,000 Value ($000) $327 Avg Close — Range —
Q1 2022
Shares 311,000 Value ($000) $585 Avg Close — Range —
Q4 2021
Shares 311,000 Value ($000) $874 Avg Close — Range —
Q3 2021
Shares 311,000 Value ($000) $1,123 Avg Close — Range —
Q2 2021
Shares 311,000 Value ($000) $1,490 Avg Close — Range —
Q1 2021
Shares 311,000 Value ($000) $2,298 Avg Close — Range —
Q4 2020
Shares 311,000 Value ($000) $2,174 Avg Close — Range —